Literature DB >> 11472006

Reduction of hyperopia associated with manual excision of Salzmann's nodular degeneration.

J G Oster1, R F Steinert, R N Hogan.   

Abstract

PURPOSE: Removing central corneal pathology often leads to a hyperopic shift secondary to corneal flattening. A myopic shift, or reduction in hyperopia, would be expected after removal of peripheral corneal pathology with central corneal steepening. This case illustrates the refractive changes induced by Salzmann's nodular degeneration and the myopic shift associated with their excision.
METHODS: A 53-year-old female presented with a slowly progressive increase in hyperopia. Vision in the right eye was 20/40 with a refraction of +10.00 -4.00 x 90 degrees. Vision in the left eye was 20/30 with a refraction of +5.75 -2.00 x 105 degrees. Both corneas exhibited nodular subepithelial opacities in the mid-periphery. A superficial keratectomy was performed on each eye, 1 year apart.
RESULTS: Twelve days postoperatively, uncorrected visual acuity in the right eye was 20/25, and 20/20 with a refraction of -0.75 -0.50 x 31 degrees, 6 months later. Six days postoperatively, uncorrected visual acuity in the left eye was 20/40, and 20/30 with a refraction of -1.25 D, 1 month later.
CONCLUSION: Superficial keratectomy provides a means of restoring the original corneal contour, especially when the pathology is easily dissected from Bowman's layer. The surgeon should investigate the refractive status prior to the development of the nodules and be aware of the possible refractive change upon removal of the pathology.

Entities:  

Mesh:

Year:  2001        PMID: 11472006     DOI: 10.3928/1081-597X-20010701-10

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  7 in total

1.  Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann's nodular degeneration.

Authors:  Gloria B Chiu; Dianne Bach; Christos Theophanous; Martin Heur
Journal:  Saudi J Ophthalmol       Date:  2014-06-18

2.  In vivo morphologic characteristics of Salzmann nodular degeneration with ultra-high-resolution optical coherence tomography.

Authors:  Volkan Hurmeric; Sonia H Yoo; Carol L Karp; Anat Galor; Lejla Vajzovic; Jianhua Wang; Sander R Dubovy; Richard K Forster
Journal:  Am J Ophthalmol       Date:  2010-12-09       Impact factor: 5.258

3.  Superficial keratectomy, PTK, and mitomycin C as a combined treatment option for Salzmann's nodular degeneration: a follow-up of eight eyes.

Authors:  Riad Khaireddin; Toam Katz; Rahul B Baile; Gisbert Richard; Stephan J Linke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-04-05       Impact factor: 3.117

4.  [Salzmann's nodular degeneration. Mostly an epithelial corneal dystrophy].

Authors:  R Sundmacher
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

5.  One year outcome of manual alcohol-assisted removal of Salzmann's nodular degeneration.

Authors:  Anna M Roszkowska; Pietro Colosi; Letteria De Grazia; Eliana Mirabelli; Giovanni Romeo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-08-06       Impact factor: 3.117

Review 6.  Phototherapeutic keratectomy.

Authors:  Varsha M Rathi; Sharadini P Vyas; Virender S Sangwan
Journal:  Indian J Ophthalmol       Date:  2012 Jan-Feb       Impact factor: 1.848

7.  Salzmann nodular degeneration: prevalence, impact, and management strategies.

Authors:  Vikram Paranjpe; Anat Galor; Pedro Monsalve; Sander R Dubovy; Carol L Karp
Journal:  Clin Ophthalmol       Date:  2019-07-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.